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Introduction
The gene-based screening allows the rapid detec-
tion of biosynthetic gene clusters in the isolated strains 
(Wood et al. 2007). In the latest years, genome min-
ing has been focused on Streptomyces and has become 
a novel and rapid method to identify the previously uni-
dentified gene clusters (Xu et al. 2019). Genes that are 
involved in the biosynthesis of secondary metabolites 
are mainly organized in the secondary metabolism bio-
synthetic gene clusters. With the progress of genomic 
sequencing technology, the mining of the organism’s 
secondary metabolism biosynthetic gene clusters 
becomes possible (Bu et al. 2019; Xu et al. 2019). Strep­
tomyces harbor over 20 secondary gene clusters encod-
ing the biosynthesis of many cryptic metabolites that 
are not expressed under standard laboratory conditions. 
The genome of Streptomyces is genetically engineered 
to remove the non-essential genes and permit hetero-
logous expression of genes encoding cryptic metabo-
lites (Komatsu et al. 2010; Wu et al. 2017; Bu et al. 2019; 
Xu et al. 2019). In most of the cases, these gene clusters 
are silent or ordinarily expressed under the specified 
laboratory conditions (Ye et al. 2017). One of the essen-
tial features of the genome in the genus Streptomyces is 
the occurrence of biosynthetic gene cassettes (Hwang 
et al. 2014). The Streptomyces coelicolor and Strepto­
myces avermitilis contain more than 20 gene clusters 
for the production of secondary metabolites and inno-
vative antibiotics (Busti et al. 2006). In the genome of 
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This study aimed to investigate the PCR-based screening strategy for the prediction of the antimicrobial biosynthetic potential of the selected 
Streptomyces strains originated from an extreme environment (Cholistan Desert, Pakistan). The biosynthetic potential was determined 
by using both molecular and culture-dependent screening approaches. The four biosynthetic genes clusters, including the pks­1, nrps, cyp 
P450 hydro xylase (cyps), and glycopeptide oxy b genes, were investigated in the selected strains by PCR amplification, sequencing, and by 
subsequent bioinformatics approaches. Among the 40 selected Streptomyces strains, 33 strains possessed the nrps gene, 17 strains carried 
the pks­1 gene, four strains were found to have the cyps gene, and none of the strain carried oxy b gene. The Streptomyces strains including 
NR-1, NR-10, NR-14, and NR-15 were investigated for in vitro antifungal activity against Fusarium oxysporum, Rhizoctonia solani, and 
Aspergillus sp. The extracts were analyzed for chemical profiling (TLC and HPLC-UV), and a unique pattern of secondary metabolites was 
observed. The selected strains exhibited pronounced antifungal activity against the fungal test strains with the zone of inhibition up to 17, 
18, and 19 mm, respectively. The study depicts that gene-based screening can be successfully applied to identify potentially bioactive strains 
by usin a single screening process. This PCR-based approach is rapid and can be used for sorting out and selecting the potential candidate 
among actinobacterial culture collections. Such a preselection or strain prioritization consequently decreases the time and efforts required 
for selecting the potential bioactive strain, which then can be subjected to the detailed chemical analysis.
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S. avermitilis there are 25 types of gene clusters for 
secondary metabolites. From the 25 genes clusters, 
eight are for type I polyketide, two for type II related 
polyketide, and eight gene clusters are involved in the 
biosynthesis of non-ribosomal peptide synthetases 
(NRPS) compounds (Omura et al. 2001).
The conventional method of natural drug discov-
ery is based on the bioactivity-guided purification of 
compounds, which is laborious and led to re-discovery 
of compounds most often. However, most of the bio-
synthetic potential of microorganisms is not detected 
under laboratory conditions (Winter et al. 2011).
The biosynthetic gene clusters for polyenes showed 
the existence of cytochrome P450 hydroxylase. The 
cytochrome P450 hydroxylase (cyps) genes performed 
different types of oxidation processes in different organ-
isms (Lamb et al. 2003). The polyene-specific cyto-
chrome P450 hydroxylase (cyps) has been found in all 
the earlier categorized polyene gene clusters, such as 
for nystatin, amphotericin, pimaricin, and candicidin 
antibiotics (Lee et al. 2006). Glycopeptides are a sig-
nificant class of antibiotics that inhibit bacterial cell 
wall synthesis (Sosio et al. 2003). Glycopeptide anti-
biotics biosynthesis gene cluster of balhimycin encodes 
the cytochrome P450 monooxygenases such as Oxya, 
Oxyb, and Oxyc that are responsible for three oxida-
tion steps and convert the linear peptide into cyclized 
form to make them chemically active. Thus, these three 
oxygenases act in a stepwise manner in the order Oxyb, 
then Oxya, and Oxyc for the formation of glycopeptide 
antibiotics (Bischoff et al. 2001). 
The genomic studies of actinomycetes indicated 
that non-ribosomal peptide synthetases and type  I 
polyketide synthases (PKS-1) contribute about half of 
the biosynthetic systems that encode the genes for the 
biosynthesis of the secondary metabolites (Komaki 
et al. 2016). The PKS type I catalyzes the synthesis of 
macrolide antibiotics including erythromycin and tylo-
sin (Le et al. 2014). The pks­1 gene codes for at least 
three domains equivalent to a ketosynthase (KS), acyl-
transferase (AT), and an acyl carrier protein (ACP) that 
enable the condensation of different subunits. All the 
PKS I domains collaborate to form a new polyketide 
chain (Ayuso-Sacido and Genilloud 2005). The non-
ribosomal peptide includes clinically essential anti-
biotics, such as cyclosporins, bleomycin, vancomycin, 
and penicillins. A representative NRPS unit consists 
of three essential domains, such as an adenylation (A) 
domain, a peptidyl carrier protein (PCP), and a con-
densation (C) domain. New domains are continually 
evolving, as novel gene clusters for peptide biosynthesis 
are being categorized (Du et al. 2000).
The PCR-based screening approach sets the stage for 
the discovery of novel metabolites. This method helped 
to meet the medical severe demand for new drug candi-
dates and enhance the acceptance of natural metabolic 
products as suitable drug candidates.
In this study, a PCR-based genome screening 
method was used for 40 independently isolated Strepto­
myces strains, and the detection of CYP specific poly-
ene (cytochrome P450 hydroxylase), the glycopeptide 
oxy b gene (cytochrome P450 monooxygenase), type I 
polyketide synthase (PKS-1), and the non-ribosomal 
peptide synthase (NRPS) gene, based on the presence 
of the expected size of the PCR amplified DNA frag-
ments, was performed. These results suggest that the 
PCR-based genome screening method is an efficient 
method for the detection of potentially valuable Strepto­
myces. The bioinformatics studies were also applied to 
confirm the presence of glycopeptide Oxyb, NRPS, and 
PKS-1 proteins, which play an important role in the 
antibiotics biosynthesis pathways. The functional analy-
sis of the sequenced strains was performed by using dif-
ferent bioinformatics tools including BLASTn, BLASTp, 
EMBOSS TRANSq, and MEGA 6.0. The biological and 
chemical analyses were performed to confirm that the 
selected Streptomyces strains can produce the antifungal 
compounds (cyps genes) under the culture condition.
Experimental
Materials and Methods
Streptomyces strains and genomic DNA extrac-
tion. A total of 40 Streptomyces strains were obtained 
from the collection of the Department of Microbio-
logy and Molecular Genetics, University of the Punjab, 
Lahore, Pakistan. The selected strains were previously 
isolated from Cholistan desert of Pakistan. The GYM-
broth (glucose 10 g, yeast extract 5 g, malt extract 5 g, 
distilled water 1,000 ml) was prepared, and 40 ml broth 
was taken in a 100 ml flask and was inoculated with the 
fresh culture of Streptomyces strains in each case. The 
flasks were incubated at 28°C on a rotatory shaker for 
about 7 days. The culture broth was taken in the Eppen-
dorf tube and centrifuged at 10,000 rpm for 2 minutes 
to get the cell pellet or mycelial mass. The cell pellet was 
further utilized for DNA extraction by using the tissue 
Genomic DNA Extraction Mini Kit (FavorPrep™). 
PCR amplification of antibiotics biosynthesis 
genes. The PCR was performed (Primus 96 (PeqLab) 
thermal cycler). All amplifications contained a  total 
volume of 50 µl with 0.5 × Master Mix (25 µl) (Thermo 
Scientific), 10 pmol of each primer (3 µl) (1 st BASE 
laboratories), 100 ng of DNA template (3 µl) and 19 µl 
of deionized water. The gradient PCR was performed 
to identify the optimum annealing temperatures for 
each pair of primers. The PCR based screening of the 
non-ribosomal peptide synthase, polyketide synthase 
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1 (pks­1), polyene specific cyp P450 hydroxylase, and 
glycopeptide oxy b genes was accomplished using the 
primers given in Table I.
Sequencing of the amplified PCR product. The 
PCR products were purified by using MicroElute gel 
extraction kit (Favorgen) and sequenced by dye termi-
nator chemistry using an automated sequencer, using 
the commercial facility of 1st BASE laboratories. The 
sequences were analyzed using the BLASTn search pro-
gram at The National Center for Biotechnology Infor-
mation (NCBI): http://www.ncbi.nlm.nih.gov/BLAST/. 
The BLASTn was performed to estimate the percent-
age homology with the reported gene clusters, and the 
sequences were submitted to NCBI, GenBank, to get 
the accession numbers.
Sequence analysis by bioinformatics tools. The 
sequences were analyzed by using various bioinformat-
ics tools, such as the nucleotide sequence was trans-
lated by using EMBOSS transq (https://www.ebi.ac.uk/
Tools/st/emboss_transeq/) into their resulted peptides 
sequence. The BLASTP (https://blast.ncbi.nlm.nih.gov/
Blast.cgi?PAGE=Proteins) of all the resultant translated 
frames was performed, to find the similarity index of 
the peptides based on the percentage similarity, the 
functional protein with the highest similarity, was 
selected from all the 6 reading frame. The translated 
sequence of Streptomyces proteins were selected for 
multiple sequence alignment by using the Clustal_W 
alignment tool built-in MEGA 6 (https://www.megas-
oftware.net/). The partial 16S rRNA sequences of the 
selected actinobacterial strains were compared using 
the BLAST tool available on NCBI. The sequences 
of closely related species were obtained from NCBI 
and aligned using the CLUSTAL_W program. The 
neighbor-joining phylogenetic tree was inferred using 
a Kimura’s 2-parameters in software MEGA 6.0. Tree 
topologies were evaluated for branch support using 
1,000 replications Fig. 1.
Preparation of cell extracts for biological and 
chemical screening. The cell extracts of actinomycetes 
were prepared by inoculating the actinomycetes cul-
tures, in the 200 ml GYM-broth, the inoculated flasks 
were incubated for 6–7 days at 28°C on the rotatory 
shaker. The cultures were sonicated in the sonicating 
Fig. 1. Neighbor-joining tree based on 16S rRNA gene sequences of closely related type strains.
Evolutionary distance was calculated using Kimura 2-parameters with 1000 bootstrap value.
cyps CYP-F TGGATCGGCGACGACCGSVYCGT 23 bp 63.8 350 bp Ayuso-Sacido and Genilloud 2005
 CYP-R CCGWASAGSAYSCCGTCGTACTT 23 bp 56.6
oxy b GLY-F CTGGTCGGCAACCTGATGGAC 21 bp 61.7 560 bp Ayuso-Sacido and Genilloud 2005
 GLY-R CAGGTACCGGATCAGCTCGTC 21 bp 61.7
pks1 K1F TSAAGTCSAACATCGGBCA 19 bp 48.4 1200–1500 bp Ayuso-Sacido and Genilloud 2005
 M6R CGCAGGTTSCSGTACCAGTA 20 bp 55.4
nrps A3F GCSTACSYSATSTACACSTCSGG 23 bp 53.1 700 bp Wood et al. 2007
 A7R SASGTCVCCSGTSCGGTAS 19 bp 50.6
Table I
PCR primers for the nrps, pks­1, cyps, and oxy b genes.
Genes Primers Sequence (5’-3’) Length Tm Product size References
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bath to break the cells, an equal volume of ethyl acetate 
was added, and the mixture was taken in a separating 
funnel and was vigorously shaken for 5–10 minutes. The 
separating funnel was kept un-disturbed; after some 
time, two distinctive layers appeared. The aqueous layer 
was separated from the organic layer carefully. The ethyl 
acetate was recycled on a rotary evaporator, and the 
extracts were obtained in methanol, and stored in clean 
vials at 4°C. These methanolic extracts were further used 
for in vitro antifungal activity and for chemical profiling, 
using TLC and HPLC/UV (Fatima et al. 2019).
Determination of the antifungal activity. The PDA 
(potato dextrose agar) plates were prepared, and the 
inverted side of the plate was marked from edge to 
about 2 cm from both sides. After marking, agar plugs 
were cut from well-grown cultures of selected actino-
mycetes, and were placed on PDA plates about 2 cm 
from the edge, and the plates were incubated for about 
2 days. After 2 days of incubation, similarly, agar plugs 
were cut from the fungal cultures, and were placed on 
the opposite side of the same plate that contained the 
actinomycetes agar plug. The plates were incubated 
for further 4 to 5 days at 27°C. After that the incubation 
zone of inhibition was measured. 
In another method, the fungal test strains, including 
F. oxysporum (FO), R. solani (RS), and Aspergillus sp. 
(FN2) were streaked on SDA (Sabourad dextrose agar). 
The fresh cultures of fungal strains were swabbed with 
the help of a cotton swab on SDA plates, and the wells 
were made with the help of a sterile cork borer in the 
plates. Further, 60 μl of methanolic extracts were loaded 
on each well, and the plates were incubated at 28°C for 
4–5 days. After incubation, the inhibition zones were 
measured in mm (Silambarasan et al. 2012).
Thin-layer chromatography (TLC). The metha-
nolic extracts were spotted on the TLC plate with the 
help of a capillary tube. The spots were air-dried, before 
developing the plate with CH2Cl2/MeOH (10%) solvent 
system. The developed air-dried TLC plates were visual-
ized under UV at 254 nm and 366 nm. The TLC plates 
were stained, by spraying with anisaldehyde/H2SO4, and 
Ehrlich’s reagents, (Merck) individually. 
High-performance liquid chromatography 
(HPLC-UV) analysis. The methanolic extracts of 
actino mycetes were analyzed, on the HPLC (Sykum 
HPLC system) by using the software clarity. The column 
used was Rp C18 with a 30 cm length. The Mobile phase 
was methanol and water (95:5), and the flow rate was 
adjusted to 1 ml/minute. The methanolic extracts were 
dissolved in HPLC grade methanol, and 20 µl of each 
extract were injected and were run for 20 minutes, the 
UV absorbance was measured at 254 nm. The peaks of 
each component were measured and were compared at 
different retention times (tR) with standard UV absorp-
tion data of secondary metabolites.
Results
About 40 selected Streptomyces strains were screened 
for the presence of cytochrome P450 hydroxylase (cyps) 
gene. Out of 40 strains (Table II), only four showed the 
presence of the cyp P450 hydroxylase gene, with the 
NR-1 MK243371 Streptomyces sp.
NR-10 MK243372 Streptomyces sp.
NR14 MK243373 Streptomyces sp.
NR15 MK243374 Streptomyces sp.
NR11 MN912434 Streptomyces sp.
C2 MN912435 Streptomyces pseudovenezuelae
D6-3 MN912436 Streptomyces flavogriseus
H34A MN912437 Streptomyces sp.
H34B MN912438 Streptomyces sp.
NR28 MN912439 Streptomyces flavoviridis
NR1 MN912440 Streptomyces sp.
NR5 MN912441 Streptomyces werraensis
10M MN912442 Streptomyces sp.
C3 MN912443 Streptomyces fenghuangensis
H32B MN912444 Streptomyces sp.
B5K MN912445 Streptomyces fimbriatus
H31A MN912446 Nocardioides sp.
M19 MN912447 Streptomyces albogriseolus
MM5 MN912448 Streptomyces Streptomyces griseus
NR3 MN912449 Streptomyces sp.
M63 MN912450 Streptomyces misionensis
M32 MN912451 Streptomyces sp.
M12 MN912452 Streptomyces steffisburgensis.
MM7 MN912453 Streptomyces fimbriatus.
M13 MN912454 Streptomyces niveoruber
D3-1 MN912455 Streptomyces bambusae
M29 MN912456 Streptomyces sp.
M28 MN912457 Streptomyces coerulescens
NR24 MN912458 Streptomyces silaceus
NR22 MN912459 Streptomyces sp.
H26 MN912460 Streptomyces steffisburgensis
M43 MN912461 Streptomyces rubrolavendulae
NR12 MN912462 Streptomyces neopeptinius
NR6 MN912463 Streptomyces coeruleoprunus
D3-3 MN912464 Streptomyces sp.
D3-2 MN912465 Streptomyces sp.
M93 KM062032 Streptomyces laurentii
M71 KM062033 Streptomyces vitaminophilus
M54 KM062034 Streptomyces hypolithicus
M51 KM062035 Streptomyces chartreusis
Table II
Streptomyces sp. GenBank accession numbers of 16S rRNA genes.
S. No.
Given Code
of Strain
GenBank
Accession
No.
Identified as
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amplicon size of 350 bp. The strains NR10, NR15, NR14, 
and NR1 were detected for the presence of the cyp P450 
hydroxylase gene. Out of 40 strains, about 33 strains 
showed the presence of the nrps gene. The nrps primer 
pair A3F/A7R amplified the band of approximately 
700 bp. The strains including NR11, C2, D6-3, H34A, 
H34B, NR28, NR1, NR5, 10M, C3, H32B, B5K, H31A, 
M19, MM5, MM63, NR3, M12, MM7, M13, NR6, M29, 
M28, NR24, NR22, H26, M43, NR12, NR6, M29, M28, 
and NR24 were found to have the nrps gene. To deter-
mine the presence of the glycopeptide oxy  b (P450 
monooxygenase) gene in selected Streptomyces strains 
the PCR utilizing the primer pair Gly-F/Gly-R, which 
amplified the 560 bp fragment was carried out. Out of 
40 strains, none of the strains exhibited the presence 
of the glycopeptide oxy b gene. The gene-specific PCR 
for pks­1 utilized the KI-F/M6-R primer set; the ampli-
fied product of the primer was about 1200–1500 bp 
gene fragment. 40 strains were screened for the pks­1 
gene; among them 17 strains were found positive for 
the pks­1 gene (Table III).
The PCR amplified gene fragments were sequenced, 
and sequence data was analyzed with the BLAST to 
check the percentage homology of the given genes such 
as the cytochrome P450 hydroxylase (cyps), glyco pep-
tide oxy b, pks­1, and non-ribosomal peptide synthase 
(nrps) genes with the other genes that are present in 
NCBI GenBank. The percentage homology of the 
amplified gene fragments in different Streptomyces 
strains with the cytochrome P450 hydroxylase (cyps) 
gene was as follows: NR-1, NR-10, and NR14 (98%, 
100%, and 100%). The percentage homology of the 
amplified genes in Streptomyces strains with non-ribo-
somal peptide synthase (nrps) gene are given as: NR-6, 
M13, M29, and NR-12 (100%, 99%, 100%, and 98%). 
The percentage homologies of Streptomyces strains with 
type 1 polyketide synthase (pks­1) were 98% for the 
strain NR-6 (Table III).
The sequences were submitted to NCBI Gen-
Bank (BANKit) as follows: strain NR-1 Accession 
No. MF279145, strain NR-10 Accession No. MF279146, 
strain NR-6 Accession No. MF279147, strain M13 
Accession No. MF279148, strain NR-12 Accession 
No. MF279150, strain NR-6 Accession No. MF27914, 
strain NR-14 Accession No. MK272790, and strain 
NR-15 Accession No. MK272791 (Table  II). The 16S 
rRNA gene accession numbers are given as follows: 
NR-1 Accession No. MK243371, NR-10 Accession 
No. MK243372, NR-14 Accession No. MK243373, and 
NR-15 Accession No. MK243374.
The nucleic acid sequence of strains NR-1, NR-10, 
NR-14, and NR-15 with the cytochrome P450 hydro-
xylase gene was translated using EMBOSS Transq. The 
similarity index of the translated nucleotide of strain 
NR-1, with cytochrome P450 hydroxylase protein from 
all six reading frames, were mentioned in Table  IV. 
The EMBOSS_001_1 showed the highest percentage 
similarity of 98% with cytochrome P450 hydroxy-
lase (CYP) protein, while the EMBOSS_001_4 indi-
cated the lowest similarity with cytochrome P450 
hydroxylase (CYP) protein. The EMBOSS_001_5 
and EMBOSS_001_6 are non-functional proteins, 
and no significant similarity was found. The protein 
sequence that showed highest similarity index were 
further selected for alignment by using the MEGA 6.0. 
It might be possible the given antifungal activity of the 
Streptomyces strains, including NR-1, NR-10, NR14, 
and NR-15, was due to the different amino acid resi-
dues within the protein sequence. The bioinformatic 
studies confirmed the presence of cytochrome P450 
hydroxylase), cytochrome P450 monooxygenase, non-
ribosomal peptide synthase, and type I polyketide syn-
thase proteins that plays a vital role in the antibiotics 
biosynthesis pathways. The biological and chemical 
screening results showed that the selected Streptomyces 
strains NR-1, NR-10, NR-14, and NR-15 can produce 
the polyene compounds under laboratory conditions.
The results of the agar plug method indicated that 
all the four strains carrying the cyp gene showed an 
1. NR-1  350 bp 98 CYP MF279145
2. NR-10  350 bp 100 CYP MF279146
3. NR14  350 bp 98 CYP MK272790
4. NR15  350 bp 98 CYP MK272791
5. NR-16  700 bp 100 NRPS MF279147
6. M13  700 bp 99 NRPS MF279148
7. NR-12  700 bp 98 NRPS MF279150
8. NR-6 1500 bp 98 PKS-1 MF279149
Table III
Streptomyces sp. GenBank accession numbers
of the genes sequences.
S.
No. Isolates
Nucleotide
length
% age
homology
Genes
encoding
for
GenBank
Accession
No.
EMBOSS_001_1 98
EMBOSS_001_2 50
EMBOSS_001_3 No significant similarity found
EMBOSS_001_4 45
EMBOSS_001_5 No significant similarity found
EMBOSS_001_6 No significant similarity found
Table IV
The translated DNA sequence of NR-1 based on six reading
frames and their percentage similarity with cytochrome P450
hydroxylase (CYP) protein.
Sequence translation
(EMBOSS Transq)
% similarity with cytochrome P450
hydroxylase protein
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inhibitory effect toward the tested fungal strains 
(Table V). The strain NR1 showed the most remarkable 
inhibitory effect on the tested fungal strains. The strains 
NR-1 and NR-14 have the most prominent inhibitory 
effect on the test strain FN2 (Fig. 2). While in the 
well-diffusion method cycloheximide (2 mg/ml) was 
used as standard, and the MM7 methanolic crude 
extract was used as the negative control. The crude 
extracts of strains NR-1, NR-10, NR-14, NR-15, 
and MM7 showed 17.0 ± 0.11 mm, 17.8 ± 0.18 mm, 
14.7 ± 0.22 mm, 16.0 ± 0.25 mm, 5.1 ± 0.121 mm zone 
of inhibition, while CHX (cycloheximide) showed 
9.9 ± 0.26 mm inhibitory zone against the F. oxyspo­
rum (FO). The selected crude extract showed the fol-
lowing zones of inhibition against the R. solani (RS): 
18.0 ± 0.32 mm, 12.2 ± 0.41 mm, 13.8 ± 0.45 mm, and 
16.6 ± 0.45 mm. The fungal strain Aspergillus (FN2) 
against which the antifungal activity was determined by 
Fusarium oxysporum 17.0 ± 0.11 17.8 ± 0.18 14.7 ± 0.22 16.0 ± 0.25 5.1 ± 0.121  9.9 ± 0.26
Rhizoctonia solani 18.0 ± 0.32 12.2 ± 0.41 13.8 ± 0.45 16.6 ± 0.45 0.2 ± 0.11 10.9 ± 0.53
Aspergillus sp. 22.1 ± 0.40 19.0 ± 0.12 18.8 ± 0.27 18.3 ± 0.38 1.7 ± 0.42 14.0 ± 0.18
Table V
Antifungal activity of the selected polyene producing Streptomyces sp. against different fungal strains
(Fusarium oxysporum, Rhizoctonia solani, and Aspergillus sp.).
The fungus strain
tested
Zone of inhibition in mm
NR-1 NR-10 NR-14 NR-15 MM7 CHX
Fig. 2. Antifungal activity of the selected polyene producing Streptomyces sp. against different fungal strains 
tested (Fusarium oxysporum (FO), Rhizoctonia solani (RS), and Aspergillus sp. (FN2). (A), (B), (C) Anti fun-
gal activity of NR-1, NR-10, and NR-15 by the agar plug method against Fusarium oxysporum (FO), Rhizocto­
nia solani (RS). (D), (E), (F) Activity of NR-1, NR-14, and NR-15 by the agar plug method against Aspergillus 
sp. (FN2). (G), (H), (I) Activity of NR-1, NR-14, NR-10, H26, and CHX (cycloheximide) by the well diffusion 
method against Aspergillus sp.
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utilizing the crude extracts of NR-1, NR-10, NR-14, and 
NR-15 strains. The strain NR-1 showed the most promi-
nent zone of inhibition which was 22.1 ± 0.40 mm, while 
NR-10, NR14, and NR-15 indicated 19.0 ± 0.12 mm, 
18.8 ± 0.27 mm, and 18.3 ± 0.38 mm zone of inhibi-
tion, respectively. The MM7 (control) did not show any 
significant zone of inhibition compared to the tested 
Streptomyces extracts (Table V).
In a thin-layer chromatography, different biologically 
active components were analyzed in the crude extracts. 
The Streptomyces strains indicated various bands, which 
were of unique color. Many components of the crude 
extract displayed UV absorbance: however, most notice-
able bands were observed in crude extracts of strains 
NR-14 and NR-1 (Fig. 3). NR-14 and NR-1 showed red, 
pink, and the most important green color band after 
spraying with anisaldehyde/H2SO4. The NR-10, NR15, 
NR 14, and NR-1 exhibited bands of yellowish, pink, and 
purple after staining with Ehrlich’s reagent.
The biologically active strains, including NR-1, 
NR10, NR14, and NR-15 that showed the presence 
of polyene specific the cytochrome P450 hydroxylase 
(cyps) gene, were further analyzed on HPLC to indicate 
either these strains had peaks related to any polyene 
compounds when grown in culture. The strain NR-1 
showed three peaks at different retention times; the 
most prominent peak was observed at tR  2.95  min-
utes. The strain NR-10 showed two peaks, but the 
most prominent peak was detected at tR 3.22 minutes. 
The other strains, which were analyzed on the HPLC 
chromatogram, included NR-14, which displayed two 
prominent bands at 2.94  minutes and 3.20  minutes 
retention time (tR). The strain NR-15 showed the most 
prominent peak at tR 3.02 minutes (Fig. 4).
Each of the HPLC/UV chromatogram of methanolic 
extract of selected Streptomyces were compared with the 
standard nystatin HPLC/UV chromatogram (Hwang 
et al. 2007). The standard nystatin displayed the peak at 
a retention time of 3.03 minutes. After that comparison, 
it was confirmed that all the strains that showed the 
presence of polyene specific CYP P450, produced some 
polyene like antifungal metabolites.
Discussion
The current advances in the field of genomics, meta-
genomics, and high-throughput screening is bene-
ficial for the natural product’s detection (Genilloud 
et al. 2011). Due to the rediscovery of the already known 
metabolites, there is a strong need to explore the unique 
habitats and ecological niches, so that the probability 
of the discovery of novel metabolites with appropriate 
bioactivities could increase (Dhaneesha et al. 2017). The 
genome mining has thus delivered a  comprehensive 
innovative tool, for the discovery of already identified, 
as well as previously unidentified natural metabolites, 
and the explanation of new biochemical revolutions 
and biosynthetic pathways (Chou et al. 2010).
Among the 40 tested Streptomyces strains only four 
strains indicated the presence of a predictable 350 bp 
PCR product for the polyene specific cytochrome P450 
hydroxylase gene. The results indicated that polyene 
gene is a rare gene because only a low hit rate was found. 
Fig. 3. Chemical profile of the selected Actinomycetes strains. (A) TLC plate at 366 nm.
(B) TLC plate after spraying with Ehrlich’s reagent. (C) TLC plate after spraying with anisaldehyde reagent.
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The use of fungal antibiotics is limited because of its 
high toxicity, so the genome-guided screening approach 
for the detection of new polyene antibiotics like com-
pounds having improved pharmacological ability and 
less cytotoxicity is welcomed (Brautaset et al. 2002).
To screen the selected Streptomyces strains for the 
detection of the glycopeptide oxy b gene a PCR was per-
formed. After optimization, not a single strain could be 
found positive for the desired gene; it might be because 
the glycopeptide gene cluster is rare. Encheva-Malinova 
et al. (2014) reported that almost all the strains pos-
sessed pks­II gene, and among the 11 strains screened 
for the nrps gene, six were positive for polyene, and 
four were positive for glycopeptide gene. The study 
confirmed that the glycopeptide antibiotics gene is 
rare among all four genes screened. In this study, for 
33 strains amplification of the 700 bp fragment was suc-
cessful that indicated the presence of the non-ribosomal 
peptide synthase gene. Gontang et al. (2010) reported 
that three primer sets for different domains of the nrps 
gene utilized for PCR based screening. The results of 
study showed that all domains were amplified in the 
isolated Streptomyces, and the biosynthetic domains 
were involved in the production of secondary metab-
olites. For the pks­1 gene, the annealing temperature 
utilized in gradient PCR was 55 ± 0.5°C for 2 minutes. 
The most appropriate PCR product of 1200–1500 bp 
was visualized at temperature 53°C. 
The in vitro antifungal assays indicated that the 
selected Streptomyces have the potential to synthesize 
the polyene specific CYPs proteins when grown in cul-
ture conditions. The published literature also indicated 
that most of the secondary metabolites from Streptomy­
ces are extracellular when grown under certain cultural 
conditions (Arasu et al. 2013).
Overall, this study revealed that a PCR-based screen-
ing approach that targets novel genes from biosynthetic 
gene clusters is a powerful tool for the rapid detection 
and identification of bioactive strains within the large 
culture collections. Moreover, in the recent past, the 
screening of large culture collections has led to the 
rediscovery of already known compounds; this greatly 
increases the usefulness of the PCR-based screening 
approach. Furthermore, in this study, a  phylogenetic 
analysis of the amplified PCR products showed the exact 
prediction of the structural class of secondary meta-
bolites being synthesized by an individual strain. The 
gene-based screening approach is helpful and can act 
as an additional pre-screening strategy for the selection 
of promising Streptomyces strains in a collection before 
cultivating the strains on a large scale for the purifica-
tion and identification of the compounds. The relative 
abundance of the selected genes is shown in Fig. 5.
Fig 4. HPLC analysis of crude extracts of the polyene producing Streptomyces sp. (A) HPLC chromatogram of strain NR-1,
(B) HPLC chromatogram of strain NR-10, (C) HPLC chromatogram of strain NR-14, (D) HPLC chromatogram of strain NR-15.
Fig. 5. The relative abundance of the nrps, pks­1, cyps, oxy b genes 
in the selected Streptomyces strains. 
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